Scholars@Duke

Uses of epoetin for anemia in oncology.

Publication ,  Journal Article
Seidenfeld, J; Aronson, N; Piper, M; Flamm, CR; Hasselblad, V; Ziegler, KM
Published in: Evid Rep Technol Assess (Summ)
March 2001
Link to item

Duke Scholars

Victor Hasselblad
Author Victor Hasselblad Biostatistics & Bioinformatics, Division of Biostatistics

Published In

Evid Rep Technol Assess (Summ)

ISSN

1530-440X

Publication Date

March 2001

Issue

30

Start / End Page

1 / 8

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Risk Assessment
  • Recombinant Proteins
  • Randomized Controlled Trials as Topic
  • Neoplasms
  • Incidence
  • Humans
  • Erythropoietin
  • Drug Administration Schedule
  • Dose-Response Relationship, Drug
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Seidenfeld, J., Aronson, N., Piper, M., Flamm, C. R., Hasselblad, V., & Ziegler, K. M. (2001). Uses of epoetin for anemia in oncology. Evid Rep Technol Assess (Summ), (30), 1–8.
Seidenfeld, J., N. Aronson, M. Piper, C. R. Flamm, V. Hasselblad, and K. M. Ziegler. “Uses of epoetin for anemia in oncology.” Evid Rep Technol Assess (Summ), no. 30 (March 2001): 1–8.
Seidenfeld J, Aronson N, Piper M, Flamm CR, Hasselblad V, Ziegler KM. Uses of epoetin for anemia in oncology. Evid Rep Technol Assess (Summ). 2001 Mar;(30):1–8.
Seidenfeld, J., et al. “Uses of epoetin for anemia in oncology.” Evid Rep Technol Assess (Summ), no. 30, Mar. 2001, pp. 1–8.
Seidenfeld J, Aronson N, Piper M, Flamm CR, Hasselblad V, Ziegler KM. Uses of epoetin for anemia in oncology. Evid Rep Technol Assess (Summ). 2001 Mar;(30):1–8.

Published In

Evid Rep Technol Assess (Summ)

ISSN

1530-440X

Publication Date

March 2001

Issue

30

Start / End Page

1 / 8

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Risk Assessment
  • Recombinant Proteins
  • Randomized Controlled Trials as Topic
  • Neoplasms
  • Incidence
  • Humans
  • Erythropoietin
  • Drug Administration Schedule
  • Dose-Response Relationship, Drug